The global brachytherapy devices market was estimated to be US$ 860.67 Million in 2022 and is expected to reach US$ 1,726.79 Million by 2032 at a CAGR of 7.2%.
Brachytherapy is one kind of radiation treatment that is utilized to treat malignancy. Brachytherapy is on a broader term called internal radiation.
Brachytherapy permits specialists to convey higher portions of radiation to more-specific areas of the body, when compared to the ordinary type of radiation treatment that is external beam radiation that projects radiation from a machine outside the human body. Brachytherapy devices are profitable over radiation treatment hardware as they deliver high accuracy to therapy of beginning phase and modest growths, and furthermore for the therapy of different diseases. This is on the grounds that brachytherapy devices empower the ideal placing of radiation material required for high dosages of radiation. Thus, this will advance the development of Brachytherapy devices market in the coming years.
Brachytherapy devices are preferred over other radiation treatment gear for cancer therapy, as patients treated through these devices have little possibility of relapse in the future. Other recently created brachytherapy procedures are Image Guided Brachytherapy (IGBT) and Pulse Dose Rate (PDR). Brachytherapy is presently supported with programming arrangements which empower the medical services suppliers for legitimate service and booking of brachytherapy for patients.
The prostate cancer segment was seen ruling the market and represented the biggest income share in 2020. Brachytherapy is a compelling therapy choice both as monotherapy and in blend with outer bar radiation treatment in all patients with constricted prostate malignant growth. The promising uses of brachytherapy in the therapy of prostate cancer are driving the segment.
The breast cancer brachytherapy application segment is postulated to observe a sizable CAGR during the forecast period. The expanding use of brachytherapy in Accelerated Partial Breast Irradiation (APBI) is one of the central point’s driving the development of this segment. Furthermore, the rising occurrence of breast cancer is likewise expected to drive the development of this segment.
In any case, the absence of expert radiotherapy experts and admittance to mechanically progressed items, especially in non-industrial nations, is relied upon to be a significant controlling element for this market. North America was seen ruling the brachytherapy market and held the biggest income share of in 2020. In Asia Pacific, the market is ready to witness the most elevated CAGR during the speculation period.
Brachytherapy Devices Market Value Share Analysis, by Geography (2022)
The report titled “Brachytherapy Devices Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032”, wherein 2021 is the historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the Brachytherapy Devices Market.
Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The Brachytherapy Devices market is segmented as Product, dosage type, application, and region. Based on product, the Brachytherapy Devices market is segmented into Seeds, Applicators, After loaders, Electronic Brachytherapy, other. Based on dosage type, the Brachytherapy Devices market is segmented into HDR Brachytherapy, LDR Brachytherapy, other. Based on application, the Brachytherapy Devices market is segmented into Prostate Cancer, Gynecological Cancer, Breast Cancer, Others.
Based on geography, the Brachytherapy Devices Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Italy, France, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, UAE, South Africa and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Brachytherapy Devices Market. Further, market share of prominent companies in the Brachytherapy Devices Market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Brachytherapy Devices companies. The Brachytherapy Devices Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the Brachytherapy Devices business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the Brachytherapy Devices Market.
The key players of the Brachytherapy Devices Market are Theragenics Corporation, Becton, Dickinson & Company, Varian Medical Systems Inc., Elekta AB, Eckert & Ziegler BEBIG, iCAD Inc., Isoray Medical Inc., CIVCO Medical Solutions, and others.
Based on product type
Based on dosage type
Based on application
By Region
The brachytherapy devices market is expected to reach US$ 1,726.79 Million by 2032.
The brachytherapy devices market is expected grow at a CAGR of 7.2% between 2023 to 2032.
The brachytherapy devices market was estimated to be US$ 860.67 Million in 2022.
Theragenics Corporation, Becton, Dickinson & Company, Varian Medical Systems Inc., Elekta AB, Eckert & Ziegler BEBIG, iCAD Inc., Isoray Medical Inc. are few prominent players active in the market.
Brachytherapy is a compelling therapy choice both as monotherapy and in blend with outer bar radiation treatment in all patients with constricted prostate malignant growth. The promising uses of brachytherapy in the therapy of prostate cancer are driving the segment.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved